Neurology
Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer’s disease – an exploratory analysis.
Neurodegenerative disease management · 2025
Abstract
This systematic review and metaregression analysis estimates the association between the delta-9-tetrahydrocannabinol (THC) dose of cannabinoid-based medicines and neuropsychiatric adverse events among adults aged 50 years and older.